Science

BioNTech, renowned for its COVID-19 vaccine, is transitioning focus to mRNA-based cancer therapies, aiming for breakthroughs by 2026. The company experienced a decrease in profits, with EPS falling from €1.90…

Kieran Agg, a PhD student from Didcot, is leading innovative research into the chemistry and physics of bio-liquids. His work is featured at the STEM for Britain event, attracting attention…